| AADI | Aadi Bioscience, Inc. | -44.51% | -30.97% | 0.00% | 90.96% | -93.19% | -0.52 |
|---|
| ABCL | AbCellera Biologics Inc. | -11.12% | -54.05% | 0.00% | 77.82% | -90.29% | -0.21 |
|---|
| ABCM | Abcam plc | -27.81% | -6.86% | 0.00% | 39.38% | -47.78% | -0.58 |
|---|
| ABEO | Abeona Therapeutics Inc. | -52.64% | -36.63% | 0.00% | 104.06% | -99.93% | -0.68 |
|---|
| ABIO | ARCA biopharma, Inc. | -2.09% | -36.96% | 0.00% | 154.25% | -99.97% | -0.17 |
|---|
| ABOS | Acumen Pharmaceuticals, Inc. | -17.16% | -59.22% | 0.00% | 115.26% | -84.81% | -0.24 |
|---|
| ABSI | Absci Corporation | -67.68% | -78.39% | 0.00% | 97.21% | -92.74% | -0.80 |
|---|
| ABUS | Arbutus Biopharma Corporation | -36.25% | -6.45% | 0.00% | 94.59% | -97.19% | -0.65 |
|---|
| ABVC | ABVC BioPharma, Inc. | -77.44% | -76.07% | 0.00% | 1,160.21% | -100.00% | -0.72 |
|---|
| ACAD | ACADIA Pharmaceuticals Inc. | -32.48% | 11.91% | 0.00% | 68.95% | -77.18% | -0.29 |
|---|
| ACER | Acer Therapeutics Inc. | -34.21% | -36.60% | 0.00% | 124.35% | -99.88% | -0.36 |
|---|
| ACET | Adicet Bio, Inc. | 10.12% | -31.21% | 0.00% | 93.49% | -95.81% | 0.94 |
|---|
| ACHL | Achilles Therapeutics plc | -65.07% | -73.78% | 0.00% | 73.19% | -91.10% | -0.92 |
|---|
| ACHV | Achieve Life Sciences, Inc. | -64.40% | -60.32% | 0.00% | 89.80% | -100.00% | -1.11 |
|---|
| ACIU | AC Immune SA | -48.08% | -25.35% | 0.00% | 78.86% | -87.82% | -0.62 |
|---|
| ACOR | Acorda Therapeutics, Inc. | -74.42% | -42.21% | 0.00% | 96.90% | -99.90% | -0.36 |
|---|
| ACRS | Aclaris Therapeutics, Inc. | 14.44% | 5.89% | 0.00% | 112.43% | -97.73% | 0.45 |
|---|
| ACXP | Acurx Pharmaceuticals, Inc. | -23.63% | -33.89% | 0.00% | 82.26% | -69.33% | -0.29 |
|---|
| ADAG | Adagene Inc. | -85.87% | -83.46% | 0.00% | 71.85% | -97.00% | -1.16 |
|---|
| ADAP | Adaptimmune Therapeutics plc | -45.07% | -23.71% | 0.00% | 116.37% | -96.57% | -0.53 |
|---|
